Liquid biopsy and PCR-free ultrasensitive detection systems in oncology

A Finotti, M Allegretti, J Gasparello… - International …, 2018 - spandidos-publications.com
In oncology, liquid biopsy is used in the detection of next-generation analytes, such as tumor
cells, cell-free nucleic acids and exosomes in peripheral blood and other body fluids from …

Low-dose CT for lung cancer screening: opportunities and challenges

H Shen - Frontiers of Medicine, 2018 - Springer
Lung cancer is among the most frequently diagnosed cancers worldwide and the leading
cause of cancer death in both males and females. Screening for lung cancer coupled with …

Correlation between progression‐free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced‐stage EGFR‐mutated non‐small cell …

Y Lee, S Park, WS Kim, JC Lee, SJ Jang… - Thoracic …, 2018 - Wiley Online Library
Background This study was conducted to identify whether the presence of circulating tumor
DNA (ctDNA) in plasma before treatment with EGFR‐tyrosine kinase inhibitors (TKIs) is …

[HTML][HTML] Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients

V Poroyko, T Mirzapoiazova, A Nam, I Mambetsariev… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Lung cancer is a devastating disease with overall bleak prognosis. Current methods to
diagnose lung cancer are rather invasive and are inadequate to detect the disease at an …

Hypermethylation of MDFI promoter with NSCLC is specific for females, non‑smokers and people younger than 65

H Ma, X Chen, H Hu, B Li, X Ying… - Oncology …, 2018 - spandidos-publications.com
Non‑small cell lung carcinoma (NSCLC) is a major subtype of lung cancer. Aberrant DNA
methylation has been frequently observed in NSCLC. The aim of the present study was to …

PAP 动态监测血浆cfDNA 在进展期非小细胞肺癌患者治疗中的应用

徐晓燕, 阎昭, 王雨萌, 孟昭婷, 陈金良, 王青山, 林丽… - 中国肿瘤临床, 2018 - cjco.cn
PAP动态监测血浆cfDNA在进展期非小细胞肺癌患者治疗中的应用 首页 期刊简介 1.期刊介绍 2.获奖
情况 编委会 期刊在线 1.最新录用 2.优先发表 3.当期目录 4.过刊浏览 视频合辑 在线投稿 1.投稿 …

Chirurgische Therapie im Stadium I und II des nichtkleinzelligen Lungenkarzinoms

LV Klotz, H Winter - Die Onkologie, 2018 - search.proquest.com
Hintergrund In den vergangenen Jahrzehnten hat sich die Prognose des Lungenkarzinoms
trotz moderner Diagnostik und multimodaler Therapiestrategien kaum verbessert. Ein großer …

Investigation of KRAS and NRAS expression levels in lung cancer patients compared to normal patients.

S Rikhtegar - Yafte, 2018 - eprints.lums.ac.ir
Background: Lung cancer is one of the most common cancers around the world, and a major
cause of death. The KRAS and NRAS genes could cause malfunction in signal transduction …

Surgical treatment of stage I and II non-small cell lung cancer

LV Klotz, H Winter - Der Onkologe, 2018 - Springer
Background Despite modern diagnostics and multimodal treatment strategies, overall
survival of lung cancer could not be significantly improved in recent decades. The majority of …

مطالعه بررسی بیان ژن های KRAS و NRAS افراد مبتلا به سرطان ریه نسبت به گروه سالم

ریخته گر, حسام پور, اردشیر - یافته, 2018‎ - yafte.lums.ac.ir
مقدمه: سرطان ریه یکی از رایج ترین انواع سرطان ها در سرتاسر دنیا است و یکی از دلایل مهم مرگ و
میر است. تغییرات بیانی در ژنهای KRAS و NRAS باعث ایجاد اختلال در انتقال سیگنال های درون …